CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
$1.12
-0.0600 ( -5.08% ) 419.9K
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
Market Data
Open
$1.12
Previous close
$1.18
Volume
419.9K
Market cap
$3.18M
Day range
$1.08 - $1.20
52 week range
$1.00 - $137.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k/a | 8K-related | 13 | Jul 12, 2024 |
8-k | 8K-related | 13 | Jul 09, 2024 |
8-k | 8K-related | 21 | Jul 03, 2024 |
8-k | 8K-related | 19 | Jun 26, 2024 |
8-k/a | 8K-related | 15 | Jun 20, 2024 |
8-k | 8K-related | 19 | Jun 14, 2024 |
8-k | 8K-related | 18 | Jun 05, 2024 |
8-k | 8K-related | 15 | May 16, 2024 |
10-q | Quarterly Reports | 43 | May 15, 2024 |
8-k | 8K-related | 13 | May 07, 2024 |